Tonghua Dongbao Pharmaceutical
Tonghua Dongbao Pharmaceutical Co Ltd is a Chinese biotechnology and pharmaceutical manufacturing enterprise headquartered in Tonghua, Jilin Province, China. The company specializes in the research, development, manufacturing, and distribution of recombinant human insulin, insulin analog products, and diabetes therapeutic treatments, operating as a leading domestic producer of diabetic care medications. Principal revenue is derived through wholesale manufacturing sales of insulin products and pharmaceutical formulations to hospitals and medical distributors. Tonghua Dongbao Pharmaceutical is publicly listed on the Shanghai Stock Exchange.
2 of the funds FundTelligence covers report a position in Tonghua Dongbao Pharmaceutical.
- Legal name
- Tonghua Dongbao Pharmaceutical Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Tonghua Dongbao Pharmaceutical
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)